Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease.
about
Risk factors and implications of anastomotic complications after surgery for Crohn's diseaseAnti-Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position PaperA review of the impact of biologics on surgical complications in Crohn's diseaseReview article: optimal preparation for surgery in Crohn's diseaseRisk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: A meta-analysis of observational studies.Perioperative Considerations in Crohn Disease and Ulcerative Colitis.Medical and surgical therapy of inflammatory bowel disease in the elderly - prospects and complications.Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis.The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease.Surgery for Crohn's disease and anti-TNF agents: the changing scenario.Is Modern Medical Management Changing Ultimate Patient Outcomes in Inflammatory Bowel Disease?Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new "biological era".Post-operative abdominal complications in Crohn's disease in the biological era: Systematic review and meta-analysis.Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients.Effect of Anti-TNF Agents on Postoperative Outcomes in Inflammatory Bowel Disease Patients: a Single Institution Experience.Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.Prognostic Nutritional Index Predicts Short-Term Postoperative Outcomes After Bowel Resection for Crohn's Disease.The impact of bacterial DNA translocation on early postoperative outcomes in Crohn's patients undergoing abdominal surgery.The effect of immune therapy on surgical site infection following Crohn's Disease resection.Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.[Refractory inflammatory bowel disease: surgical challenges].[Multimodal oncological therapy concepts, chemotherapy and immunosuppressive drugs: effects on surgical morbidity and mortality].Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.Impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn's disease: a single-center paired case-control study.Surgical Considerations in the Treatment of Small Bowel Crohn's Disease.[Perioperative handling of immunosuppressive therapy].Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease-Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome.
P2860
Q26777503-30517337-F052-4689-AB66-310BD7C10AC5Q26783978-62265695-36DD-437E-9C52-40BE831D80DDQ26865009-A8753C32-F7D5-47A7-8EE9-A7D9222A0896Q27025900-93416AD2-258F-4292-9583-B18A12C72EA3Q35540491-61BE2209-82DC-4C79-B74B-FF1C5520576DQ36940448-A3AB32A8-B831-46BD-93F1-08A156FF0374Q37875963-3FD6E8E2-F580-41F1-9983-D91AA90C956BQ37998988-D7999CC5-020A-4AA1-A5DF-877F683DDD20Q38087143-4D2F4DF6-3CBB-435F-BD09-FEF5D4D745F6Q38098574-241E3311-A51A-4E7B-A7A2-44F7A7A1F158Q38155663-6AAC4075-7D25-46E8-9B17-2E03F2877B15Q38407096-B2876775-544B-4BA3-88EC-E3652ADA809DQ38635824-D55EB9A1-B043-4739-8E59-6D254584C074Q38791996-F454D76A-B860-4D53-8DFF-AABEFA48D5ADQ38820319-AFAD163F-4F58-49B6-9178-956F00451866Q38894023-1B1E3383-D20F-4D0E-AA73-53B75B0374CFQ40416993-FE606E66-9EEC-4821-86CC-19E45B4F1AA5Q40561491-C6B34EAD-AB0B-4C60-A732-52D9CE10BA39Q41630782-B1B7988C-763D-42C3-9660-5666F36C7AAAQ42263986-3ADE64DB-2EDB-4041-9BCA-D923DF07F82DQ42271558-A96A903C-D4F2-413A-B89E-AE861A7DFAE9Q43577963-2F875046-AB5A-4F10-B862-D18327224F11Q44650345-5F1BC4CB-30C5-411D-A48D-588222BDC279Q44775146-AF304F26-25EA-4D91-9FA6-A5A593864D9FQ46275695-B9E55F87-DBE2-48E8-A708-9E3FCA3CAF20Q46346648-C409601B-4DAC-49D1-963A-DF38B1DAD0F8Q49630842-73E99DEA-AF33-48FA-AA28-55024229997CQ50996989-827D11F9-CA28-4D9D-9FDB-F7DE9B4B3AC6
P2860
Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Perioperative anti-tumor necro ...... plications in Crohn's disease.
@en
Perioperative anti-tumor necro ...... plications in Crohn's disease.
@nl
type
label
Perioperative anti-tumor necro ...... plications in Crohn's disease.
@en
Perioperative anti-tumor necro ...... plications in Crohn's disease.
@nl
prefLabel
Perioperative anti-tumor necro ...... plications in Crohn's disease.
@en
Perioperative anti-tumor necro ...... plications in Crohn's disease.
@nl
P2093
P1476
Perioperative anti-tumor necro ...... plications in Crohn's disease.
@en
P2093
Basil S Nasir
Bruce G Wolff
David W Larson
Eric J Dozois
John H Pemberton
Robert R Cima
P2888
P304
1859-65; discussion 1865-6
P356
10.1007/S11605-010-1341-5
P577
2010-09-25T00:00:00Z